Pancreatic Proton Density Fat Fraction Is Already Elevated in Prediabetes but Shows No Further Increase in Diabetic Nephropathy: A Retrospective Magnetic Resonance Imaging Study

Background/Objectives: The stage at which intrapancreatic fat begins to rise, and whether it tracks microvascular complications, are unresolved. We determined whether pancreatic proton density fat fraction (PDFF) rises stepwise across four stages of metabolic deterioration, and tested its independence from adiposity and hepatic fat and its relation to diabetic nephropathy (DN). Methods: In this retrospective cross-sectional study at a tertiary care center, consecutive adults in four clinically defined glycemic categories (normoglycemic, prediabetes, type 2 diabetes (T2D) without DN, T2D with DN) underwent 1.5-T abdominal magnetic resonance imaging with three-dimensional mDIXON-Quant. Two blinded abdominal radiologists measured pancreatic PDFF and T2* in consensus; hepatic PDFF was measured on the same maps. Results: In total, 216 adults were analyzed (59, 57, 60 and 40 per group, respectively), and hepatic PDFF was measurable in 162. Pancreatic PDFF rose across the groups (median 2.36%, 4.69%, 6.68% and 6.68%; Jonckheere–Terpstra Z = 10.578, p < 0.001), the largest step being normoglycemia to prediabetes (+3.04 percentage points, p < 0.001), where hepatic PDFF did not change (p = 0.175). Disease stage remained independently associated with log10 pancreatic PDFF after adjustment including hepatic PDFF (β = 0.554, p < 0.001), which itself was not (p = 0.327). Pancreatic PDFF did not differ between the T2D groups (−0.46 percentage points, 95% CI −2.86 to +1.94; Cohen’s d = −0.078) and was unrelated to renal function or albuminuria. Conclusions: Intrapancreatic fat is already almost twofold elevated in prediabetes, independently of hepatic steatosis, but rises no further once nephropathy is established. Because chemical shift–encoded sequences are routine in abdominal magnetic resonance imaging, pancreatic PDFF is obtainable without extra scan time and may flag prediabetic individuals for earlier metabolic management.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2026-11-18
DOI
https://doi.org/10.3390/jcm15229038
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Pancreatic Proton Density Fat Fraction Is Already Elevated in Prediabetes but Shows No Further Increase in Diabetic Nephropathy: A Retrospective Magnetic Resonance Imaging Study

Mehmet Yaşar, Gökhan İpek
2 links
Journal of Clinical Medicine
Liver Disease Diagnosis and Treatment
article

Pancreatic Proton Density Fat Fraction Is Already Elevated in Prediabetes but Shows No Further Increase in Diabetic Nephropathy: A Retrospective Magnetic Resonance Imaging Study

Mehmet Yaşar, Gökhan İpek
article en

Abstract

Background/Objectives: The stage at which intrapancreatic fat begins to rise, and whether it tracks microvascular complications, are unresolved. We determined whether pancreatic proton density fat fraction (PDFF) rises stepwise across four stages of metabolic deterioration, and tested its independence from adiposity and hepatic fat and its relation to diabetic nephropathy (DN). Methods: In this retrospective cross-sectional study at a tertiary care center, consecutive adults in four clinically defined glycemic categories (normoglycemic, prediabetes, type 2 diabetes (T2D) without DN, T2D with DN) underwent 1.5-T abdominal magnetic resonance imaging with three-dimensional mDIXON-Quant. Two blinded abdominal radiologists measured pancreatic PDFF and T2* in consensus; hepatic PDFF was measured on the same maps. Results: In total, 216 adults were analyzed (59, 57, 60 and 40 per group, respectively), and hepatic PDFF was measurable in 162. Pancreatic PDFF rose across the groups (median 2.36%, 4.69%, 6.68% and 6.68%; Jonckheere–Terpstra Z = 10.578, p < 0.001), the largest step being normoglycemia to prediabetes (+3.04 percentage points, p < 0.001), where hepatic PDFF did not change (p = 0.175). Disease stage remained independently associated with log10 pancreatic PDFF after adjustment including hepatic PDFF (β = 0.554, p < 0.001), which itself was not (p = 0.327). Pancreatic PDFF did not differ between the T2D groups (−0.46 percentage points, 95% CI −2.86 to +1.94; Cohen’s d = −0.078) and was unrelated to renal function or albuminuria. Conclusions: Intrapancreatic fat is already almost twofold elevated in prediabetes, independently of hepatic steatosis, but rises no further once nephropathy is established. Because chemical shift–encoded sequences are routine in abdominal magnetic resonance imaging, pancreatic PDFF is obtainable without extra scan time and may flag prediabetic individuals for earlier metabolic management.

Journal of Clinical MedicineVol. 15(22)
Sağlık Bilimleri Üniversitesi (TR)
Good health and well-being
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon